Literature DB >> 20351792

Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Nehal P Vadhan1, Mark R Serper, Margaret Haney.   

Abstract

This article reviews the literature on the acute effects of Delta 9-tetrahydrocannabinol, the primary psychoactive component of marijuana, on working memory, and the implications for schizophrenia. Working memory deficits are a hallmark feature of schizophrenia, and have been implicated as an etiologic mechanism contributing to the onset of the disorder. Regular marijuana smokers may also exhibit subtle working memory impairment relative to healthy controls, and an association between marijuana abuse and subsequent development of schizophrenia, though controversial, has been reported in the literature. The causal role that marijuana plays in working memory impairment related to schizophrenia, however, remains unclear. Thus, this article specifically considers the acute effects of marijuana on working memory performance. The ecologic relevance and clinical significance of these findings will be examined, and directions for future research will be recommended.

Entities:  

Year:  2009        PMID: 20351792      PMCID: PMC2846369     

Source DB:  PubMed          Journal:  Prim psychiatry        ISSN: 1082-6319


  71 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

3.  Application of a computational decision model to examine acute drug effects on human risk taking.

Authors:  Scott D Lane; Eldad Yechiam; Jerome R Busemeyer
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

4.  Acute marijuana effects on human risk taking.

Authors:  Scott D Lane; Don R Cherek; Oleg V Tcheremissine; Lori M Lieving; Cythia J Pietras
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

Review 5.  Working memory dysfunction in schizophrenia.

Authors:  P S Goldman-Rakic
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

6.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

7.  Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.

Authors:  H Verdoux; C Gindre; F Sorbara; M Tournier; J D Swendsen
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

Review 8.  The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.

Authors:  Carissa M Coulston; Michael Perdices; Christopher C Tennant
Journal:  Aust N Z J Psychiatry       Date:  2007-11       Impact factor: 5.744

Review 9.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

10.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

View more
  6 in total

1.  Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Authors:  Nehal P Vadhan; Cheryl M Corcoran; Gill Bedi; John G Keilp; Margaret Haney
Journal:  Psychiatry Res       Date:  2017-08-01       Impact factor: 3.222

2.  Delay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys.

Authors:  Christopher D Verrico; Shijing Liu; Elizabeth J Bitler; Hong Gu; Allan R Sampson; Charles W Bradberry; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

3.  Specificity of verbal learning impairment and recovery in a marijuana-dependent male: the effects of sustained marijuana abstinence.

Authors:  Nehal P Vadhan; Wilfred G van Gorp; Frances R Levin
Journal:  Cogn Neuropsychiatry       Date:  2011-01-20       Impact factor: 1.871

4.  Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.

Authors:  Christopher D Verrico; David S Mathai; Hong Gu; Allan R Sampson; David A Lewis
Journal:  J Psychopharmacol       Date:  2019-10-17       Impact factor: 4.153

5.  Δ9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial.

Authors:  Kirsten C S Adam; Manoj K Doss; Elisa Pabon; Edward K Vogel; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2020-05-09       Impact factor: 7.853

Review 6.  The effect of cannabis use on memory function: an update.

Authors:  Tabea Schoeler; Sagnik Bhattacharyya
Journal:  Subst Abuse Rehabil       Date:  2013-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.